Low body mass index and old age are useful in predicting the hemoglobin A1c-lowering effect of switching from sitagliptin to dulaglutide in Japanese patients with type 2 diabetes mellitus: a single-center, open-label, single-arm, pilot study

AIMS: The purpose of this study was to clarify the predictive clinical characteristics of therapy switching from sitagliptin to dulaglutide in patients with type 2 diabetes mellitus. METHODS: This single-center, open-label, investigator-initiated pilot study was conducted in 40 patients with type 2...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetol Int
Hlavní autoři: Iwasaki, Tomoyuki, Kessoku, Takaomi, Higurashi, Takuma, Taguri, Masataka, Yoneda, Masato
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Japan 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6224913/
https://ncbi.nlm.nih.gov/pubmed/30603366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-018-0348-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky